Daniel D. Shoemaker, Chief Scientific Officer at FATE THERAPEUTICS INC (FATE), sold 49,900 shares at $19.49 ($973K) on 2019-12-30, disclosed to the SEC on 2020-01-02.
Open-market sale of $973k FATE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.49 | 24,900 | $485K | 49.9% |
| 2 | $19.49 | 24,900 | $485K | 49.9% |
| 3 | $20.34 | 100 | $2K | 0.2% |
| Total | $19.49 avg | 49,900 | $973K | 100% |
| Filing → |
| FATE | SELL | 2020-11-16 | $2.6M | — | Filing → |
| FATE | SELL | 2020-09-16 | $1.8M | — | Filing → |
| FATE | SELL | 2020-01-10 | $118K | — | Filing → |